Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth

Diane Warden, Geetha A. Subramaniam, Thomas Carmody, George E. Woody, Abu Minhajuddin, Sabrina A. Poole, Jennifer Potter, Marc Fishman, Michael Bogenschutz, Ashwin Patkar, Madhukar H. Trivedi

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: In opioid dependent youth there is substantial attrition from medication-assisted treatment. If youth at risk for attrition can be identified at treatment entry or early in treatment, they can be targeted for interventions to help retain them in treatment. Methods: Opioid dependent adolescents and young adults (n. =. 152), aged 15-21, were randomized to 12. weeks (BUP, n. =. 74) or 2. weeks of detoxification (DETOX, n. =. 78) with buprenorphine/naloxone (Bup/Nal), both in combination with 12. weeks of psychosocial treatment. Baseline and early treatment related predictors of treatment attrition were identified in each group using bivariate and multivariate logistic regression. Results: In the DETOX group 36% left between weeks 2 and 4, at the end of the dose taper, while in the BUP group only 8% left by week 4. In the BUP group, early adherence to Bup/Nal, early opioid negative urines, use of any medications in the month prior to treatment entry, and lifetime non-heroin opioid use were associated with retention while prior 30-day hallucinogen use was associated with attrition. In the DETOX group, only use of sleep medications was associated with retention although not an independent predictor. A broad range of other pre-treatment characteristics was unrelated to attrition. Conclusions: Prompt attention to those with early non-adherence to medication or an early opioid positive urine, markers available in the first 2. weeks of treatment, may improve treatment retention. Extended Bup/Nal treatment appeared effective in improving treatment retention for youth with opioid dependence across a wide range of demographics, and pre-treatment clinical characteristics.

Original languageEnglish (US)
Pages (from-to)1046-1053
Number of pages8
JournalAddictive Behaviors
Volume37
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Opioid Analgesics
Therapeutics
Hallucinogens
Detoxification
Naloxone Drug Combination Buprenorphine
Logistics
Urine
Medication Adherence
Young Adult
Sleep
Logistic Models
Demography

Keywords

  • Adherence
  • Adolescents
  • Buprenorphine
  • Opioid dependence
  • Retention
  • Youth

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Toxicology
  • Medicine (miscellaneous)

Cite this

Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. / Warden, Diane; Subramaniam, Geetha A.; Carmody, Thomas; Woody, George E.; Minhajuddin, Abu; Poole, Sabrina A.; Potter, Jennifer; Fishman, Marc; Bogenschutz, Michael; Patkar, Ashwin; Trivedi, Madhukar H.

In: Addictive Behaviors, Vol. 37, No. 9, 09.2012, p. 1046-1053.

Research output: Contribution to journalArticle

Warden, D, Subramaniam, GA, Carmody, T, Woody, GE, Minhajuddin, A, Poole, SA, Potter, J, Fishman, M, Bogenschutz, M, Patkar, A & Trivedi, MH 2012, 'Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth', Addictive Behaviors, vol. 37, no. 9, pp. 1046-1053. https://doi.org/10.1016/j.addbeh.2012.04.011
Warden, Diane ; Subramaniam, Geetha A. ; Carmody, Thomas ; Woody, George E. ; Minhajuddin, Abu ; Poole, Sabrina A. ; Potter, Jennifer ; Fishman, Marc ; Bogenschutz, Michael ; Patkar, Ashwin ; Trivedi, Madhukar H. / Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. In: Addictive Behaviors. 2012 ; Vol. 37, No. 9. pp. 1046-1053.
@article{dfd3c14f09fd4c0c94552c4a65f27fd1,
title = "Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth",
abstract = "Background: In opioid dependent youth there is substantial attrition from medication-assisted treatment. If youth at risk for attrition can be identified at treatment entry or early in treatment, they can be targeted for interventions to help retain them in treatment. Methods: Opioid dependent adolescents and young adults (n. =. 152), aged 15-21, were randomized to 12. weeks (BUP, n. =. 74) or 2. weeks of detoxification (DETOX, n. =. 78) with buprenorphine/naloxone (Bup/Nal), both in combination with 12. weeks of psychosocial treatment. Baseline and early treatment related predictors of treatment attrition were identified in each group using bivariate and multivariate logistic regression. Results: In the DETOX group 36{\%} left between weeks 2 and 4, at the end of the dose taper, while in the BUP group only 8{\%} left by week 4. In the BUP group, early adherence to Bup/Nal, early opioid negative urines, use of any medications in the month prior to treatment entry, and lifetime non-heroin opioid use were associated with retention while prior 30-day hallucinogen use was associated with attrition. In the DETOX group, only use of sleep medications was associated with retention although not an independent predictor. A broad range of other pre-treatment characteristics was unrelated to attrition. Conclusions: Prompt attention to those with early non-adherence to medication or an early opioid positive urine, markers available in the first 2. weeks of treatment, may improve treatment retention. Extended Bup/Nal treatment appeared effective in improving treatment retention for youth with opioid dependence across a wide range of demographics, and pre-treatment clinical characteristics.",
keywords = "Adherence, Adolescents, Buprenorphine, Opioid dependence, Retention, Youth",
author = "Diane Warden and Subramaniam, {Geetha A.} and Thomas Carmody and Woody, {George E.} and Abu Minhajuddin and Poole, {Sabrina A.} and Jennifer Potter and Marc Fishman and Michael Bogenschutz and Ashwin Patkar and Trivedi, {Madhukar H.}",
year = "2012",
month = "9",
doi = "10.1016/j.addbeh.2012.04.011",
language = "English (US)",
volume = "37",
pages = "1046--1053",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth

AU - Warden, Diane

AU - Subramaniam, Geetha A.

AU - Carmody, Thomas

AU - Woody, George E.

AU - Minhajuddin, Abu

AU - Poole, Sabrina A.

AU - Potter, Jennifer

AU - Fishman, Marc

AU - Bogenschutz, Michael

AU - Patkar, Ashwin

AU - Trivedi, Madhukar H.

PY - 2012/9

Y1 - 2012/9

N2 - Background: In opioid dependent youth there is substantial attrition from medication-assisted treatment. If youth at risk for attrition can be identified at treatment entry or early in treatment, they can be targeted for interventions to help retain them in treatment. Methods: Opioid dependent adolescents and young adults (n. =. 152), aged 15-21, were randomized to 12. weeks (BUP, n. =. 74) or 2. weeks of detoxification (DETOX, n. =. 78) with buprenorphine/naloxone (Bup/Nal), both in combination with 12. weeks of psychosocial treatment. Baseline and early treatment related predictors of treatment attrition were identified in each group using bivariate and multivariate logistic regression. Results: In the DETOX group 36% left between weeks 2 and 4, at the end of the dose taper, while in the BUP group only 8% left by week 4. In the BUP group, early adherence to Bup/Nal, early opioid negative urines, use of any medications in the month prior to treatment entry, and lifetime non-heroin opioid use were associated with retention while prior 30-day hallucinogen use was associated with attrition. In the DETOX group, only use of sleep medications was associated with retention although not an independent predictor. A broad range of other pre-treatment characteristics was unrelated to attrition. Conclusions: Prompt attention to those with early non-adherence to medication or an early opioid positive urine, markers available in the first 2. weeks of treatment, may improve treatment retention. Extended Bup/Nal treatment appeared effective in improving treatment retention for youth with opioid dependence across a wide range of demographics, and pre-treatment clinical characteristics.

AB - Background: In opioid dependent youth there is substantial attrition from medication-assisted treatment. If youth at risk for attrition can be identified at treatment entry or early in treatment, they can be targeted for interventions to help retain them in treatment. Methods: Opioid dependent adolescents and young adults (n. =. 152), aged 15-21, were randomized to 12. weeks (BUP, n. =. 74) or 2. weeks of detoxification (DETOX, n. =. 78) with buprenorphine/naloxone (Bup/Nal), both in combination with 12. weeks of psychosocial treatment. Baseline and early treatment related predictors of treatment attrition were identified in each group using bivariate and multivariate logistic regression. Results: In the DETOX group 36% left between weeks 2 and 4, at the end of the dose taper, while in the BUP group only 8% left by week 4. In the BUP group, early adherence to Bup/Nal, early opioid negative urines, use of any medications in the month prior to treatment entry, and lifetime non-heroin opioid use were associated with retention while prior 30-day hallucinogen use was associated with attrition. In the DETOX group, only use of sleep medications was associated with retention although not an independent predictor. A broad range of other pre-treatment characteristics was unrelated to attrition. Conclusions: Prompt attention to those with early non-adherence to medication or an early opioid positive urine, markers available in the first 2. weeks of treatment, may improve treatment retention. Extended Bup/Nal treatment appeared effective in improving treatment retention for youth with opioid dependence across a wide range of demographics, and pre-treatment clinical characteristics.

KW - Adherence

KW - Adolescents

KW - Buprenorphine

KW - Opioid dependence

KW - Retention

KW - Youth

UR - http://www.scopus.com/inward/record.url?scp=84862665021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862665021&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2012.04.011

DO - 10.1016/j.addbeh.2012.04.011

M3 - Article

VL - 37

SP - 1046

EP - 1053

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 9

ER -